SARS-CoV-2 entry in host cells-multiple targets for treatment and prevention
- PMID: 32479856
- PMCID: PMC7258854
- DOI: 10.1016/j.biochi.2020.05.012
SARS-CoV-2 entry in host cells-multiple targets for treatment and prevention
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new viral disease that has gained global attention owing to its ability to provoke community and health-care-associated outbreaks of severe infections in human populations. The virus poses serious challenges to clinical management because there are still no approved anti- SARS-CoV-2 drugs available. In this mini-review, we summarize the much updated published reports that demonstrate the mechanism of SARS-CoV-2 entry into host cells, and discuss the availability and development of attractive host-based therapeutic options for SARS-CoV-2 infections.
Keywords: ACE2; Drugs; Entry; Proteases; SARS-CoV-2.
Copyright © 2020 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare no conflict of interest.
Figures
References
-
- Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention [published online ahead of print, 2020 feb 24] J. Am. Med. Assoc. 2020 doi: 10.1001/jama.2020.2648. 10.1001/jama.2020.2648. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
